Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Acute phase proteins (APPs) are highly conserved plasma proteins that are increasingly secreted by the liver in response to a variety of injuries, independently of their location and cause. APPs favor the systemic regulation of defense, coagulation, proteolysis, and tissue repair. Various APPs have been applied as general diagnostic parameters for a long time. Through proteomic techniques, more and more APPs have been discovered to be differentially altered. Since they are not consistently explainable by a stereotypic hepatic expression of sets of APPs, most of these results have unfortunately been neglected or attributed to the nonspecificity of the acute phase reaction. Moreover, it appears that various extrahepatic tissues are also able to express APPs. These extrahepatic APPs show focally specific roles in tissue homeostasis and repair and are released primarily into interstitial and distal fluids. Since these focal proteins might leak into the circulatory system, mixtures of hepatic and extrahepatic APP species can be expected in blood. Hence, a selective alteration of parts of APPs might be expected. There are several hints on multiple molecular forms and fragments of tissue‐derived APPs. These differences offer the chance for multiple selective determinations. Thus, specific proteoforms might indeed serve as tissue‐specific disease indicators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · cited 9×
“Hemopexin Hpx Scavenging free heme, antioxidants, protease [13,35] Binding/transport of essentials Ceruloplasmin Cpl Iron and copper homeostasis Antiproteases 1-Antichymotrypsin AAC Enzyme inhibition [13] Antithrombin AT Enzyme inhibition 1-Antitrypsin AAT Enzyme inhibition [36] 2-Macroglobulin 2M Enzyme inhibition, i…”
BackgroundInfluentialDAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794 · cited 1×
“Abbreviations: AAG, alpha 1-acid glycoprotein; AAT, alpha 1antitrypsin; APP(s), acute phase protein(s); APR, acute phase reaction; BALF, bronchoalveolar lavage fluid; CRP, c-reactive protein; Cf, complement factor; DAMP, danger-associated molecular pattern; Hpt, haptoglobin; Hpx, hemopexin; Lf, lactoferrin; LBP, lipop…”
Sano, T., Huang, W., Hall, J. A., Yang, Y., Chen, A., Gavzy, S. J., Lee, J.-Y., Ziel, J. W., Miraldi, E. R., Domingos, A. I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.061 · Cited by 547
Regulation of iron transport and the role of transferrin
Gkouvatsos, K., Papanikolaou, G., & Pantopoulos, K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.013 · Cited by 518
Lactoferrin a multiple bioactive protein: an overview
García-Montoya, I. A., Cendón, T. S., Arévalo-Gallegos, S., & Rascón-Cruz, Q. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.06.018 · Cited by 473
Lactoferrin: Multifunctional roles of lactoferrin: a critical overview
Ward, P. P., Paz, E., & Conneely, O. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5369-8 · Cited by 443
Bode, J. G., Albrecht, U., Häussinger, D., Heinrich, P. C., & Schaper, F. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.09.008 · Cited by 379
Antiviral properties of lactoferrin--a natural immunity molecule
Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., & Valenti, P. (2011) · Molecules · doi:10.3390/molecules16086992 · Cited by 356 · cited 1×
“Moreover, Lf is able to activate various signaling pathways [135,139].”
BackgroundDAMP Signaling is a Key Pathway Inducing Immune Modulation after Brain Injury
Liesz, A., Dalpke, A., Mracsko, E., Roth, S., Zhou, W., Yang, H., Na, S.-Y., Akhisaroglu, M., Fleming, T., Eigenbrod, T., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2439-14.2015 · Cited by 334
Heme scavenging and the other facets of hemopexin
Tolosano, E., Fagoonee, S., Morello, N., Vinchi, F., & Fiorito, V. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2787 · Cited by 272
Cited by
Inflammatory Effects of High and Moderate Intensity Exercise—A Systematic Review
Cerqueira, É., Marinho, D. A., Neiva, H. P., & Lourenço, O. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01550 · Cited by 533
Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., et al. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00091 · Cited by 321
Joshi, V., Gupta, V. K., Bhanuprakash, A. G., Mandal, R. S. K., Dimri, U., & Ajith, Y. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.01.001 · Cited by 75
IL-6 and the dysregulation of immune, bone, muscle, and metabolic homeostasis during spaceflight
Smith, J. K. (2018) · npj Microgravity · doi:10.1038/s41526-018-0057-9 · Cited by 56
El-Deeb, W., Elsohaby, I., Fayez, M., Mkrtchyan, H. V., El-Etriby, D., & ElGioushy, M. (2020) · Acta Tropica · doi:10.1016/j.actatropica.2020.105336 · Cited by 50
Metadata
- Authors
- Schrödl, W., Büchler, R., Wendler, S., Reinhold, P., Muckova, P., Reindl, J., & Rhode, H.
- Venue
- PROTEOMICS – Clinical Applications
- Publisher
- Wiley
- Published
- 2016-07-04
- Volume
- 10
- Issue
- 11
- Pages
- 1077-1092
- ISSN
- 1862-8346 (ISSN-L)
- 1862-8354
- OpenAlex
- W2419146347
- Cited by
- 97
- References
- 15
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine. https://app.cochat.ai/papers/10.1002/prca.201600028
- The paper
- Schrödl, W., Büchler, R., Wendler, S., Reinhold, P., Muckova, P., Reindl, J., & Rhode, H. (2016). Acute phase proteins as promising biomarkers: Perspectives and limitations for human and veterinary medicine. PROTEOMICS – Clinical Applications. https://doi.org/10.1002/prca.201600028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.